quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:26:55·64d
INSIDERFiling
Bionano Genomics Inc. logo

CHIEF OPERATING OFFICER Oldakowski Mark covered exercise/tax liability with 20 shares, decreasing direct ownership by 2% to 895 units (SEC Form 4)

BNGO· Bionano Genomics Inc.
Industrials
Original source

Companies

  • BNGO
    Bionano Genomics Inc.
    Industrials

Recent analyst ratings

  • Nov 15UpdateLadenburg Thalmann-
  • Sep 10UpdateBTIG Research-
  • Jan 5UpdateScotiabank$4.00
  • Dec 12UpdateBTIG Research$3.50
  • Jul 18UpdateOppenheimer$12.00

Related

  • SEC21d
    SEC Form DEFA14A filed by Bionano Genomics Inc.
  • SEC21d
    SEC Form DEF 14A filed by Bionano Genomics Inc.
  • SEC29d
    SEC Form S-8 filed by Bionano Genomics Inc.
  • SEC31d
    SEC Form 10-K filed by Bionano Genomics Inc.
  • SEC31d
    Bionano Genomics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR31d
    Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
  • PR37d
    Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
  • PR45d
    Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022